Literature DB >> 3718012

Regressive systemic sclerosis.

C Black, P Dieppe, T Huskisson, F D Hart.   

Abstract

Systemic sclerosis is a disease which usually progresses or reaches a plateau with persistence of symptoms and signs. Regression is extremely unusual. Four cases of established scleroderma are described in which regression is well documented. The significance of this observation and possible mechanisms of disease regression are discussed.

Entities:  

Mesh：

Year:  1986        PMID： 3718012      PMCID： PMC1001896          DOI： 10.1136/ard.45.5.384

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


  10 in total

1.  Pathogenesis of systemic sclerosis: a vascular hypothesis.

Authors:  P M Campbell; E C LeRoy
Journal:  Semin Arthritis Rheum       Date:  1975-05       Impact factor: 5.532

2.  Biosynthesis and maturation of skin collagen in scleroderma, and effect of D-penicillamine.

Authors:  C M Herbert; K A Lindberg; M I Jayson; A J Bailey
Journal:  Lancet       Date:  1974-02-09       Impact factor: 79.321

3.  Increased frequency of HLA-DR5 in scleroderma.

Authors:  D D Gladman; E C Keystone; M Baron; P Lee; D Cane; H Mervert
Journal:  Arthritis Rheum       Date:  1981-06

4.  Increased frequency of B8/DR3 in scleroderma and association of the haplotype with impaired cellular immune response.

Authors:  C G Kallenberg; J M Van der Voort-Beelen; J D'Amaro; T H The
Journal:  Clin Exp Immunol       Date:  1981-03       Impact factor: 4.330

5.  Genetic susceptibility to scleroderma-like syndrome induced by vinyl chloride.

Authors:  C M Black; K I Welsh; A E Walker; R M Bernstein; L J Catoggio; A R McGregor; J K Jones
Journal:  Lancet       Date:  1983-01-01       Impact factor: 79.321

6.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

7.  Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome.

Authors:  E M Tan; G P Rodnan; I Garcia; Y Moroi; M J Fritzler; C Peebles
Journal:  Arthritis Rheum       Date:  1980-06

8.  Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients.

Authors:  T A Medsger; A T Masi; G P Rodnan; T G Benedek; H Robinson
Journal:  Ann Intern Med       Date:  1971-09       Impact factor: 25.391

9.  HLA antigens, autoantibodies and clinical subsets in scleroderma.

Authors:  C M Black; K I Welsh; P J Maddison; M I Jayson; R M Bernstein
Journal:  Br J Rheumatol       Date:  1984-11

10.  Immunological mechanisms in the pathogenesis of vinyl chloride disease.

Authors:  A M Ward; S Udnoon; J Watkins; A E Walker; C S Darke
Journal:  Br Med J       Date:  1976-04-17
  10 in total
  1 in total

Review 1.  Calcineurin inhibitors in systemic sclerosis - a systematic literature review.

Authors:  Nina N Hofmann; Robert A Ambühl; Suzana Jordan; Oliver Distler
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-05-19       Impact factor: 3.625
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.